A comparative study of Oral doxophylline along with Inhaler therapy and only inhaler therapy in Chronic obstructive pulmonary disease patients.
Not Applicable
- Conditions
- Health Condition 1: J449- Chronic obstructive pulmonary disease, unspecifiedHealth Condition 2: J988- Other specified respiratory disorders
- Registration Number
- CTRI/2024/08/071763
- Lead Sponsor
- SRM medical college hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
At least 6 months of diagnosis of chronic obstructive pulmonary disease, according to GOLD guidelines.(Baseline post bronchodilator forced expiratory volume is less than 50% of predicted value.)
Exclusion Criteria
.Patient with bronchial asthma, tuberculosis, lung tumour, bronchiectasis, pneumonia or other diseases that might affect pulmonary function or ventilation.
2. Patients with acute exacerbation of COPD.
3.Patients with congestive heart failure, unstable arrhythmias, chronic hypotension, active peptic ulcer disease, recent myocardial infarction and severe liver/kidney disease.
4.Patients who are unable to take Dry powder/Metered dose inhaler effectively even after adequate training.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method